Combined USA-RXE company has lost almost 13% of market cap since the merger was announced (from $139.4K to $121.6K). Based on current mcap and proposed USA share it's currently undervalued by 8.5% while RXE is overvalued by 20+%. Just an arithmetic... which often means more than fundamentals... especially short term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.